
Johnson & Johnson stock hits near 52-week high; hold advised amid strong growth and cautious outlook.
Johnson & Johnson's stock reached $270.24, close to its 52-week high of $276.47, following raised full-year guidance and FDA approval of a new robotic surgical system. The company shows strong growth in oncology and immunology, with key products like...


